Sign Up to like & get recommendations! 1
Published in 2021 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2021.0580
Abstract: Importance The peritoneal surface is a common site of disease in ovarian and colorectal cancer. Peritoneal metastases carry a poor prognosis, despite maximal therapeutic efforts, including surgical removal of tumor deposits and intravenous chemotherapy. Hyperthermic… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.24632
Abstract: Morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) for colorectal peritoneal carcinomatosis (PC) may negatively affect survival. The objective was to determine the impact of postoperative complications (CX) on survival in patients undergoing CRS + HIPEC… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.25939
Abstract: Over the past decade, there has been a considerable increase in the utilization of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of patients with peritoneal metastases. This is due to improved… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.26969
Abstract: Failure to rescue (FTR) is defined as death after a major complication. We evaluated FTR after cytoreductive surgery (CRS) with and without hyperthermic intraperitoneal chemotherapy (HIPEC). read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.27122
Abstract: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS‐HIPEC) is an effective surgical intervention for peritoneal surface malignancy. The effect of myometrium invasion on outcomes is unknown. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.27125
Abstract: The aim of this study is to evaluate the progression‐free survival (PFS) of recurrent ovarian cancer (ROC) patients treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC). read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.27143
Abstract: We aim to assess the quality and readability of online information available to patients considering cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS‐HIPEC). read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Abdominal Radiology"
DOI: 10.1007/s00261-018-1675-0
Abstract: PET in patients selected for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): methodological issues on diagnostic value and reliability Siamak Sabour , Saeid Fallah, and Sajjad Rahimi Pordanjani Department of Clinical Epidemiology, School of Public… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "International Journal of Colorectal Disease"
DOI: 10.1007/s00384-025-04863-4
Abstract: Sarcopenia has recently been gaining importance due to its role on mortality and mobility in diseases and operations. In this study, we aimed to evaluate the effect of sarcopenia on major postoperative complications in patients… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Surgical Endoscopy"
DOI: 10.1007/s00464-024-11199-7
Abstract: Open cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a therapeutic option for the management of malignancies with peritoneal carcinomatosis and of peritoneal origin. Robotic surgery shows promise as a minimally invasive approach for… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Surgery Today"
DOI: 10.1007/s00595-020-02180-7
Abstract: The prognosis of peritoneal carcinomatosis is poor. However, the emergence of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) as a treatment option has prolonged survival and it can even potentially cure patients with peritoneal carcinomatosis.… read more here.